Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Pantoprazole for GERD (TOP-GERD)
NCT06991348Phase 4Recruiting
- Sponsor
- Carnot Laboratorios
- Start
- Jul 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegoprazan in gastroesophageal reflux disease (GERD), sponsored by Carnot Laboratorios. Started Jul 2024; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT06991348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06991348.